摘要Parkinson's disease is the second most common neurodegenerative disorder.ATPase H+transporting V0 subunit A1(ATP6V0A1)is a component of vacuolar H+-ATPase(V-ATPase),an ATP-dependent proton pump.Our previous research identified an association between the ATP6V0A1 rs601999 variant and Parkinson's disease;however,the underlying mechanisms of ATP6V0A1 in Parkinson's disease remain elusive.In this study,we generated ATP6V0A1 knockdown and overexpression models and then examined the degeneration of dopaminergic neurons,lysosomal function,and the autophagy-lysosomal pathway using immunohistochemistry,western blotting,and transmission electron microscopy.We found that ATP6V0A1 protected against lysosomal dysfunction,regulated autophagic flux,and decreased phosphorylated α-synuclein levels in vitro.In vivo,ATP6V0A1 reduced levels of α-synuclein and phosphorylated α-synuclein proteins,mitigated degeneration of dopaminergic neurons,and improved motor dysfunction.Collectively,these findings show that ATP6V0A1 plays a protective role in Parkinson's disease by modulating the autophagy-lysosomal pathway.A correlation between ATP6V0A1 and Parkinson's disease susceptibility may serve as a biomarker for Parkinson's disease,while the protective effects of ATP6V0A1 could represent a potential therapeutic target for the disease.